ArticleInfluenza and other respiratory viruses2026
Hospital Admissions for Respiratory Syncytial Virus (RSV) Among Elderly: A Retrospective Study From an Italian Southern Region During Years 2018-2023.
Article in Influenza and other respiratory viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRespiratory syncytial virus (RSV) is one of the most common causes of acute respiratory infections in both children and adults over 60. RSV can cause severe lower respiratory tract infections in older adults, leading to an increase of morbidity and mortality. The aim of this study was to assess the incidence of hospitalizations due to RSV infections in the Abruzzo region of Italy among patients aged over 60 years.
methodsA retrospective study was performed in the Abruzzo region, evaluating all hospitalizations performed during years 2018-2023. Age- and gender-standardized hospitalization rates for RSV were calculated. Patients' comorbidities and hospitalization-related outcomes were also assessed.
resultsDuring 2018-2023, 42 RSV-coded hospitalizations were identified among adults aged ≥ 60 years. An additional RSV-attributable burden was estimated by applying a literature-derived attributable fraction to hospitalizations for unspecified viral bronchiolitis and pneumonia, resulting in an estimated total of 67 RSV-attributable admissions. Annual age- and sex-standardized RSV-coded hospitalization rates showed substantial year-to-year variability. Poisson regression with correction for overdispersion identified no statistically significant temporal trend during the study period (IRR per calendar year 1.08, 95% CI 0.86-1.34; p = 0.516). Among patients with RSV-coded admissions, the median length of stay was 11 days (IQR 6-18), and four patients (9.52%) died during hospitalization.
conclusionsRSV was associated with a measurable burden of hospitalization among older adults in Abruzzo. However, substantial year-to-year variability and the small number of RSV-coded admissions warrant cautious interpretation of temporal patterns. No statistically significant temporal trend was identified during the study period.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.